Quality of survival: a new concept framework to assess the quality of prolonged life in cancer

References

• Moser EC. Meunier F: cancer survivorship: A positive side-effect of more successful cancer treatment. Eur J Cancer. 2014;12:1–4.
   Google Scholar
• International Agency for Research on Cancer: Globocan 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012, 3 [ Update Nov 2015]. Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx
   Google Scholar
• Eggermont AM, Kroemer G, Zitvogel L. Immunotherapy and the concept of a clinical cure. Eur J Cancer. 2013;49:2965–2967.
   Google Scholar
• Henick BS, Herbst RS. Goldberg SB: the PD-1 pathway as a therapeutic target to overcome immune escape mechanisms in cancer. Expert Opin Ther Targets. 2014;18:1407–1420.
   Google Scholar
• Burkett VS. Cleeland CS: symptom burden in cancer survivorship. J Cancer Surviv. 2007;1:167–175.
   Google Scholar
• Shi Q, Smith TG, Michonski JD, et al. Symptom burden in cancer survivors 1 year after diagnosis: A report from the American Cancer Society’s Studies of Cancer Survivors. Cancer. 2011;117:2779–2790.
   Google Scholar
• Jacobsen PB. Jim HS: consideration of quality of life in cancer survivorship research. Cancer Epidemiol Biomarkers Prev. 2011;20:2035–2041.
   Google Scholar
• Yang P, Cheville AL, Wampfler JA, et al. Quality of life and symptom burden among long-term lung cancer survivors. J Thorac Oncol. 2012;7:64–70.
   Google Scholar
• Tevaarwerk AJ, Lee JW, Sesto ME, et al. Employment outcomes among survivors of common cancers: the Symptom Outcomes and Practice Patterns (SOAPP) study. J Cancer Surviv. 2013;7:191–202.
   Google Scholar
• Wu HS, Harden JK. Symptom burden and quality of life in survivorship: A review of the literature. Cancer Nurs. 2015;38:E29–E54.
   Google Scholar
• Burg MA, Adorno G, Lopez ED, et al. Current unmet needs of cancer survivors: analysis of open-ended responses to the American Cancer Society Study of Cancer Survivors II. Cancer. 2015;121:623–630.
   Google Scholar
• Shilling V, Matthews L, Jenkins V, et al. Patient-reported outcome measures for cancer caregivers: a systematic review. Qual Life Res. 2016;25:1859–1876.
   Google Scholar
• Longo C, Fitch M, Deber R, et al. Financial and family burden associated with cancer treatment in Ontario, Canada. Support Care Cancer. 2006;14:1077–1085.
   Google Scholar
• Persson C, Ostlund U, Wennman-Larsen A, et al. Health-related quality of life in significant others of patients dying from lung cancer. Palliat Med. 2008;22:239–247.
   Google Scholar
• Palos GR, Hare M. Patients, family caregivers, and patient navigators: a partnership approach. Cancer. 2011;117:3592–3602.
   Google Scholar
• Ellis J. The impact of lung cancer on patients and carers. Chron Respir Dis. 2012;9:39–47.
   Google Scholar
• Mosher CE, Champion VL, Azzoli CG, et al. Economic and social changes among distressed family caregivers of lung cancer patients. Support Care Cancer. 2013;21:819–826.
   Google Scholar
• Goren A, Gilloteau I, Penrod JR, et al. Assessing the burden of caregiving for patients with lung cancer in Europe. Poster presented at: ISPOR 16th Annual European Congress. Dublin, Ireland: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). 2013 Nov 2-6. Poster # PCN63.
   Google Scholar
• McCabe MS, Bhatia S, Oeffinger KC, et al. American society of clinical oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol. 2013;31:631–640.
   Google Scholar
• Robert C, Long GV, Brady B, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med. 2015;372:320–330.
   Google Scholar
• Cetin K, Ettinger DS, Hei YJ, et al. Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program. Clin Epidemiol. 2011;3:139–148.
   Google Scholar
• American cancer society: what are the survival rates for melanoma skin cancer by stage? [cited 2016 Aug 2]. Available from: http://www.cancer.org/cancer/skincancer-melanoma/detailedguide/melanoma-skin-cancer-survival-rates
   Google Scholar
• Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18:59–82.
   Google Scholar
• Sawyers CL, Abate-Shen C, Anderson KC, et al.; AACR Cancer Progress Report Writing Committee. AACR Cancer progress report 2013. Clin Cancer Res. 2013;19:S4–S98.
   Google Scholar
• American Cancer Society. Cancer treatment and survivorship facts & figures 2012-2013, 2012. [cited 2016 Aug 2]. Available from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-033876.pdf
   Google Scholar
• Clark EJ. You Have the Right to be Hopeful. A publication of the National Coalition for Cancer Survivorship; Maryland, USA: National Coalition for Cancer Survivorship. 2008. Available from: http://www.canceradvocacy.org/wp-content/uploads/2013/01/Hopeful1.pdf
   Google Scholar
• Office of Cancer Survivorship (OCS). [cited 2016 Aug 2]. Available from: http://cancercontrol.cancer.gov/ocs/statistics/definitions.html
   Google Scholar
• National Cancer Survivorship Initiative (NCSI). [cited 2016 Aug 2]. Available from: http://www.ncsi.org.uk/wp-content/uploads/NCSI-Vision-Document.pdf
   Google Scholar
• Institute of Medicine: From Cancer Patient to Cancer Survivor. Lost in Transition. Washington, DC: National Academies Press; 2006. Available from: http://www.iom.edu/Reports/2005/From-Cancer-Patient-to-Cancer-Survivor-Lost-in-Transition.aspx
   Google Scholar
• Bastian A, Ringwelski M, Patel A, Patient-centered outcomes in phase II/III and phase III oncology indications – Are manufacturers focusing on the patient? Presented at: ISPOR 18th annual international meeting. 2013. Available from: http://blog.gfk.com/wp-content/uploads/2013/08/GfK-PRO-Paper.pdf
   Google Scholar
• Wagstaff A. Beyond survival – What should new cancer drugs have to prove and how? 2011. [cited 2016 Aug 2]. Available from: http://www.cancerworld.org/Articles/Issues/43/July-August-2011/Cutting-Edge/478/Beyond-Survival-what-should-new-cancer-drugs-have-to-prove-and-how.html
   Google Scholar
• Paddock C: Measuring quality of life important in cancer survival research, [cited 2016 Aug 2]. Available from: http://www.medicalnewstoday.com/articles/236810.php
   Google Scholar
• de Souza JA, Yap BJ, Hlubocky FJ, et al. The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer. 2014;120:3245–3253.
   Google Scholar
• Trojanowski T, Peszyński J, Turowski K, et al. Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy. J Neurosurg. 1989;70:18–23.
   Google Scholar
• Nõu E, Aberg T. Quality of survival in patients with surgically treated bronchial carcinoma. Thorax. 1980;35:255–263.
   Google Scholar
• Halpern MT, McCabe MS. Burg MA: the cancer survivorship journey: models of care, disparities, barriers, and future directions. Am Soc Clin Oncol Educ Book. 2016;35:231–239.
   Google Scholar
• O’Malley D, Hudson SV, Nekhlyudov L, et al. Learning the landscape: implementation challenges of primary care innovators around cancer survivorship care. J Cancer Surviv. 2016 Jun 8. DOI: https://doi.org/10.1007/s11764-016-0555-2. [ Epub ahead of print].
   Google Scholar
• Gass J, Dupree B, Pruthi S, et al. Breast cancer survivorship: why, what and when? Ann Surg Oncol. 2016 July 18. [ Epub ahead of print].
   Google Scholar
• Nekhlyudov L, Walker R, Ziebell R, et al. Cancer survivors’ experiences with insurance, finances, and employment: results from a multisite study. J Cancer Surviv. 2016 June 9. [ Epub ahead of print].
   Google Scholar
• Gelber RD, Goldhirsch A, Cole BF, et al. A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer. J Natl Cancer Inst. 1996;88:1039–1045.
   Google Scholar
• Weinstein MC, Torrance G. McGuire A: qALYs: the basics. Value Health. 2009;12:S5–S9.
   Google Scholar
• Parry C, Kent EE, Forsythe LP, et al. Can’t see the forest for the care plan: A call to revisit the context of care planning. J Clin Oncol. 2013;31:2651–2653.
   Google Scholar
• Ramsey S, Schickedanz A. How should we define value in cancer care? Oncologist. 2010;15:1–4.
   Google Scholar
• Bell K, Ristovski-Slijepcevic S. Cancer survivorship: why labels matter. J Clin Oncol. 2013;31:409–411.
   Google Scholar
• Tralongo P, Annunziata MA, Santoro A, et al. Beyond semantics: the need to better categorize patients with cancer. J Clin Oncol. 2013;31:2637–2638.
   Google Scholar